#ASCO14 - Poster: Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo

CHICAGO, IL USA (UroToday.com) - Presented by Michael J. Morris,1 Yohann Loriot,2 Tomasz M. Beer,3 Celestia S. Higano,4 Andrew J. Armstrong,5 Cora N. Sternberg,6 Johann De Bono,7 Bertrand Tombal,8 Sarah B. Noonberg,9 Hank Mansbach,9 Suman Bhattacharya,9 Frank Perabo,10 De Phung,10 and Dana E. Rathkopf1 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

asco 2014 morris PREVAIL thumb

1Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY USA
2Institut Gustave Roussy, University of Paris Sud, Villejuif, France
3OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR USA
4Seattle Cancer Care Alliance, University of Washington, Seattle, WA USA
5Duke University Medical Center Duke Cancer Institute Divisions of Medical Oncology and Urology, Duke University, Durham, NC USA
6San Camillo and Forlanini Hospitals, Rome, Italy
7Royal Marsden Hospital and Institute of Cancer Research, London, UK
8Cliniques Universitaires Saint-Luc, Brussels, Belgium
9Medivation Inc., San Francisco, CA USA
10Astellas Pharma Global Development, Inc., Northbrook, IL USA

 

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Virtual Congress / September 19-21
  • 2020 BCAN Think Tank Virtual / August 7
  • 2020 Virtual Education Program / August 8-10
  • 2020 Annual Meeting / July 17-19 / EAU Virtual Program
  • SUO - AUA 2020 Summer Webcast / July 18
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Annual Meeting / October 3 - October 5 / Aarhus, Denmark
  • 2019 Annual Congress / September 27 - October 1 / Barcelona, Spain
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland